Purdue Pharma Names Jean-Jacques Charhon Chief Financial Officer

June 1, 2015

Purdue Pharma, a leading specialty pharmaceutical company, today announced that Jean-Jacques "JJ" Charhon has joined the company as Executive Vice President and Chief Financial Officer.

PRESS RELEASE

Stamford, Conn. (June 1, 2015)— Purdue Pharma, a leading specialty pharmaceutical company, today announced that Jean-Jacques “JJ” Charhon has joined the company as Executive Vice President and Chief Financial Officer, responsible for Purdue’s financial, procurement, and information technology functions.

“JJ is a proven leader with experience in the pharmaceutical, healthcare, and technology industries,” said Purdue President & CEO Mark Timney. “His expertise and proven record of success leading finance organizations will be a valuable asset to Purdue’s growth strategy.”

JJ joins Purdue from Cnova, one of the largest global eCommerce companies, where he served as Executive Vice President and Chief Financial Officer, with responsibility for investor relations, planning, and external reporting.

Prior to joining Cnova, JJ worked for four years for Hewlett Packard, where he joined as Chief Financial Officer of the PC division before becoming Chief Operating Officer of Enterprise Services, a $23 billion division of HP. This role followed eight years at General Electric and four years at Novartis, where he held various Global Financial Leadership roles of increasing responsibility. His last role at Novartis was Global Head of Business Planning, Analysis & Investor Relations.

JJ earned his Baccalaureate in Math, Physics & Chemistry at the French Lycee of Brussels, and holds a Master in Business Administration from the Universite Libre de Bruxelles — Solvay School of Management.